Qiagen Draws Early Takeover Interest From EQT, Advent
Qiagen NV, the European molecular testing company, is drawing early takeover interest from firms including EQT AB and Advent, people familiar with the matter said.
By Eyk Henning, Swetha Gopinath, Manuel Baigorri · Bloomberg Markets
Qiagen NV, the European molecular testing company, is drawing early takeover interest from firms including EQT AB and Advent, people familiar with the matter said.